Jane Street Group, LLC Zymeworks Inc. Transaction History

Jane Street Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $161,317 - $257,761	-34,692 Reduced 48.68%	36,572 $225,000
Q2 2022 Aug 16, 2022	BUY	$4.82 - $7.7 $228,670 - $365,303	47,442 Added 199.15%	71,264 $378,000
Q1 2022 May 17, 2022	BUY	$6.0 - $16.98 $48,192 - $136,383	8,032 Added 50.87%	23,822 $156,000
Q4 2021 Feb 15, 2022	BUY	$15.19 - $29.33 $14,339 - $27,687	944 Added 6.36%	15,790 $259,000
Q3 2021 Nov 16, 2021	BUY	$27.35 - $37.28 $105,024 - $143,155	3,840 Added 34.89%	14,846 $431,000
Q2 2021 Aug 16, 2021	BUY	$26.5 - $38.23 $68,953 - $99,474	2,602 Added 30.96%	11,006 $382,000
Q1 2021 May 18, 2021	SELL	$29.83 - $56.81 $296,182 - $564,066	-9,929 Reduced 54.16%	8,404 $265,000
Q3 2020 Nov 17, 2020	BUY	$29.21 - $46.58 $196,349 - $313,110	6,722 Added 57.89%	18,333 $854,000
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $281,915 - $578,227	11,611 New	11,611 $412,000
Q3 2019 Nov 14, 2019	SELL	$22.78 - $29.08 $218,528 - $278,964	-9,593 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$15.0 - $22.49 $143,895 - $215,746	9,593 New	9,593 $211,000
Q1 2019 May 16, 2019	SELL	$14.02 - $16.74 $1.08 Million - $1.29 Million	-76,803 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$10.95 - $15.44 $840,992 - $1.19 Million	76,803 New	76,803 $1.13 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $856M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.